Ayangade O, Akinyemi A
Department of Obstetrics, Gynecology & Perinatology, Faculty of Health Sciences, Obafemi Awolowo University, Ile-Ife, Nigeria.
Int J Gynaecol Obstet. 1989 Oct;30(2):165-70. doi: 10.1016/0020-7292(89)90312-3.
A comparative analysis of those women on Norinyl 1/35 versus those on Lo-Ovral showed those on Norinyl 1/35 were significantly (P less than or equal to 0.05) older than women in the Lo-Ovral group. There were no significant differences (P greater than or equal to 0.05) between the groups for other characteristics at admission. There were no significant differences (P greater than or equal to 0.05) between the groups at follow-up in the number of women reporting serious complications, menstrual complaints or other pill-related problems. The continuation rates at 12 months were 79.4 for the Norinyl 1/35 group and 76.7 for the Lo-Ovral groups. There were no pregnancies reported during the study period.
对服用诺孕酯炔雌醇片1/35的女性与服用低剂量炔诺孕酮炔雌醇片的女性进行的比较分析显示,服用诺孕酯炔雌醇片1/35的女性比服用低剂量炔诺孕酮炔雌醇片的女性年龄显著更大(P≤0.05)。入院时,两组在其他特征方面无显著差异(P≥0.05)。随访时,两组在报告严重并发症、月经问题或其他与避孕药相关问题的女性数量上无显著差异(P≥0.05)。诺孕酯炔雌醇片1/35组12个月时的持续服药率为79.4%,低剂量炔诺孕酮炔雌醇片组为76.7%。研究期间未报告妊娠情况。